Treatment

• President Trump issued an Executive Order directing the Department of Health and Human Services to expedite access to treatments for patients with serious mental illness. • The FDA is accelerating its review process for mental health therapies in response to the directive. • This policy shift aims to reduce barriers to treatment approval and expand therapeutic options for affected patients.

Chemicals known to affect brains of common garden birds, and to kill unborn chicks, found in most feather samplesConservationists have called for restrictions on pet flea treatments after research found songbird feathers widely contaminated with substances that can damage the birds’ brains and kill unborn chicks.Almost every feather sample tested from five common species of UK garden birds contained either permethrin, imidacloprid or fipronil – all insecticides that are banned for agricultural use but still common in pet tick and flea treatments. Continue reading...

• President Trump signed an executive order directing federal regulators to fast-track FDA review of psychedelic drugs including psilocybin and ibogaine for treating depression, anxiety, and PTSD. • The order allocates $50 million in federal funds to states implementing or developing psychedelic treatment programs as part of a federal-state partnership initiative. • Trump highlighted that over 14 million American adults have serious mental illness, with approximately 8 million on prescription medication, framing psychedelics as addressing a national mental health crisis including suicide prevention.

• President issues executive order on April 18, 2026, to speed medical treatments for serious mental illness using psychedelic drugs including ibogaine compounds. • Order highlights clinical studies showing potential for patients with persistent conditions unresponsive to standard therapies. • Directs federal agencies to prioritize research, approvals, and access to innovative mental health interventions nationwide.

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaineDonald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs.The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, a drug that US military veteran groups have said can help treat post-traumatic stress disorder. Continue reading...

Exclusive: ministers consider restricting pesticide-based treatments, which can get into waterways and harm wildlifePet owners across the UK could be banned from buying flea treatment for cats and dogs under new government rules.Ministers have begun an eight-week consultation on letting only veterinary practitioners or pharmacists give out the potent, pesticide-based flea treatments, to ensure “correct usage”. At the moment, the flea and tick treatments can be bought from any pet shop. Continue reading...

• Britney Spears has voluntarily entered a substance abuse treatment facility in Los Angeles more than a month after being arrested on suspicion of driving under the influence. • The pop icon's decision to seek treatment comes as she continues to navigate personal challenges following her conservatorship termination. • The move marks a significant moment in Spears' ongoing recovery journey, with sources close to the singer indicating her commitment to addressing substance abuse concerns.